Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas

Leukemia and Lymphoma

Volumn 53, Issue 4, 2012, Pages 624-631

  Pasanen, Anna Kaisa ^a   Kuitunen, Hanne ^a   Haapasaari, Kirsi Maria ^a   Karihtala, Peeter ^a   Kyllönen, Heli ^a   Soini, Ylermi ^b   Turpeenniemi Hujanen, Taina ^a   Kuittinen, Outi ^a  

^a UNIVERSITY OF OULU   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

8 OHdG; Antioxidant enzyme; Immunohistochemistry; Nitrotyrosine; Survival

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GLUTAMATE CYSTEINE LIGASE; MANGANESE SUPEROXIDE DISMUTASE; PARAFFIN; PREDNISONE; RITUXIMAB; THIOREDOXIN; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE; STAINING; TISSUE SECTION;

ADULT; DEOXYGUANOSINE; DISEASE-FREE SURVIVAL; FEMALE; GLUTAMATE-CYSTEINE LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUPEROXIDE DISMUTASE; THIOREDOXINS; TUMOR MARKERS, BIOLOGICAL; TYROSINE;

EID: 84859015840     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.624226     Document Type: Article

References (31)

1. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 2007;115:81-103.
2. Toyokuni S, Okamoto K, Yodoi J, et al. Persistent oxidative stress in cancer. FEBS Lett 1995;358:1-3.
3. Jaruga P, Zastawny TH, Skokowski J, et al. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 1994;341:59-64.
4. Landriscina M, Maddalena F, Laudiero G, et al. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Sign 2009;11:2701-2716.
5. Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer. Blood Cell Mol Dis 2005;34:206-213.
6. Clayton A, Turkes A, Navabi H, et al. Induction of heat shock proteins in B-cell exosomes. J Cell Sci 2005;118:3631-3638.
7. Hedlund M, Nagaeva O, Kargl D, et al. Th ermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One 2011;6:e16899.
8. Sheridan J, Wang LM, Tosetto M, et al. Nuclear oxidative damage correlates with poor survival in colorectal cancer. Brit J Cancer 2009;100:381-388.
9. Karihtala P, Soini Y, Vaskivuo L, et al. DNA adduct 8- hydroxydeoxyguanosine, a novel putative marker of prognostic signifi cance in ovarian carcinoma. Intl J Gynecol Cancer 2009;19:1047-1051.
10. Murtas D, Piras F, Minerba L, et al. Nuclear 8-hydroxy-2 ' - deoxyguanosine as survival biomarker in patients with cutaneous melanoma. Oncol Rep 2010;23:329-335.
11. Sova H, Jukkola-Vuorinen A, Puistola U, et al. 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer. Brit J Cancer 2010;102:1018-1023.
12. Karihtala P, Kauppila S, Puistola U, et al. Divergent behavior of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis. Histopathology 2011;56:854-862.
13. Ekmekcioglu S, Ellerhorst J, Smid CM, et al. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 2000;6:4768-4775.
14. Kato H, Miyazaki T, Yoshikawa M, et al. Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma. Anticancer Res 2001;21:3323-3329.
15. Karihtala P, Kinnula V, Soini Y. Antioxidative response for nitric oxide production in breast carcinoma. Oncol Rep 2004;12:755-759.
16. Kinnula VL, Crapo JD. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 2004;36:718-744.
17. Raff el J, Bhattacharyya AK, Gallegos A, et al. Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J Lab Clin Med 2003;142:46-51.
18. Yokomizo A, Ono M, Nanri H, et al. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 1995;55:4293-4296.
19. Iwao-Koizumi K, Matoba R, Ueno N, et al. Prediction of docetaxel response in human breast cancer by gene expression profi ling. J Clin Oncol 2005;3:422-431.
20. Bailey HH, Gipp JJ, Ripple M, et al. Increase in gammaglutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res 1992;52: 5115-5118.
21. Soini Y, Nä pä nkangas U, Järvinen K, et al. Expression of gammaglutamyl cysteine synthetase in nonsmall cell lung carcinoma. Cancer 2001;92:2911-2919.
22. Tome ME, Johnson DBF, Rimsza LM, et al. A redox signature score identifi es diff use large B-cell patients with a poor prognosis. Blood 2005;106:3594-3601.
23. Andreadis C, Gimotty PA, Wahl P, et al. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diff use large B-cell lymphoma. Blood 2007;109: 3409-3416.
24. Cooke MS, Olinski R, Evans MD. Does measurement of oxidative damage to DNA have clinical signifi cance? Clin Chim Acta 2006;365: 30-49.
25. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983; 52:711-760.
26. Yamane Y, Furuichi M, Song R, et al. Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol chem 1998;273: 31075-31085.
27. Tipnis SR, Blake DG, Shepherd AG, et al. Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine. Biochem J 1999;337:559-566.
28. Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Biophy Biomol Struct 2001;30:421-455.
29. Hirota K, Murata M, Sachi Y, et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 1999;274: 27891-27897.
30. Davis RE, Brown KD, Siebenlist U, et al. Constitutive nuclear factor B activity is required for survival of activated B cell-like diff use large B cell lymphoma cells. J Exp Med 2001;194:1861-1874.
31. Küp pers R. Molecular biology of Hodgkin lymphoma. Hematology/ American Society of Hematology. Educ Program 2009;1:491-496.